The declared dividend brings the company’s indicated annual rate to $4.20 per share. Headquartered in Franklin Lakes, New Jersey, the firm continues to focus on its core medical technology segments, including biopharma systems, connected care, and interventional medicine. With a global workforce exceeding 60,000 employees, the company maintains its position as a major supplier of medical essentials, aiming to drive clinical efficiency and patient safety across global healthcare systems.
Becton, Dickinson and Company Maintains Quarterly Dividend at $1.05
The board of directors at Becton, Dickinson and Company has authorized a quarterly cash dividend of $1.05 per common share. This payout, reflecting the medical technology firm’s ongoing capital allocation strategy, is scheduled for distribution to shareholders of record as of September 9, 2026, with payment set for September 30.
Comments (0)
No comments yet. Be the first!